- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech High Growth Potential Companies
Norwegian Pharmaceuticals & Biotech High Growth Potential Companies
Results
3
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
3 companies
ArcticZymes Technologies
Market Cap: NOK 1.3b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
AZT
NOK 25.70
7D
0.8%
1Y
45.4%
Photocure
Market Cap: NOK 1.5b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 57.30
7D
-3.7%
1Y
7.7%
Navamedic
Market Cap: NOK 383.3m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.70
7D
3.3%
1Y
-29.3%